Tumor NGS Genetic Testing - Global and China Top Players Market Share and Ranking 2023

Tables and Figures

Table 1. Tumor NGS Genetic Testing Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Tumor NGS Genetic Testing Market Restraints
Table 3. Tumor NGS Genetic Testing Market Trends
Table 4. Tumor NGS Genetic Testing Industry Policy
Table 5. Global Tumor NGS Genetic Testing Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Tumor NGS Genetic Testing Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Tumor NGS Genetic Testing Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global Tumor NGS Genetic Testing Mergers & Acquisitions, Expansion Plans
Table 9. Global Tumor NGS Genetic Testing Major Companies Product Type
Table 10. Head Office and Area Served of Key Players
Table 11. China Tumor NGS Genetic Testing Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 12. China Tumor NGS Genetic Testing Revenue Market Share by Company, 2018-2023
Table 13. Global Key Players of Tumor NGS Genetic Testing Upstream (Raw Materials)
Table 14. Global Tumor NGS Genetic Testing Typical Customers
Table 15. Tumor NGS Genetic Testing Typical Distributors
Table 16. By Type, Global Tumor NGS Genetic Testing Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 17. By Application, Global Tumor NGS Genetic Testing Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 18. By Region, Global Tumor NGS Genetic Testing Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 19. By Region, Global Tumor NGS Genetic Testing Consumption Value, 2018-2029, US$ Million
Table 20. By Country, Global Tumor NGS Genetic Testing Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 21. By Country, Global Tumor NGS Genetic Testing Consumption Value, 2018-2029, US$ Million
Table 22. By Country, Global Tumor NGS Genetic Testing Consumption Value Market Share, 2018-2029
Table 23. Foundation Medicine Company Information, Head Office, Market Area and Industry Position
Table 24. Foundation Medicine Company Profile and Main Business
Table 25. Foundation Medicine Tumor NGS Genetic Testing Models, Specifications, and Application
Table 26. Foundation Medicine Tumor NGS Genetic Testing Revenue and Gross Margin, US$ Million, 2018-2023
Table 27. Foundation Medicine Recent Developments
Table 28. Guardant Health Company Information, Head Office, Market Area and Industry Position
Table 29. Guardant Health Company Profile and Main Business
Table 30. Guardant Health Tumor NGS Genetic Testing Models, Specifications, and Application
Table 31. Guardant Health Tumor NGS Genetic Testing Revenue and Gross Margin, US$ Million, 2018-2023
Table 32. Guardant Health Recent Developments
Table 33. Illumina Company Information, Head Office, Market Area and Industry Position
Table 34. Illumina Company Profile and Main Business
Table 35. Illumina Tumor NGS Genetic Testing Models, Specifications, and Application
Table 36. Illumina Tumor NGS Genetic Testing Revenue and Gross Margin, US$ Million, 2018-2023
Table 37. Illumina Recent Developments
Table 38. Thermo Fisher Scientific Inc. Company Information, Head Office, Market Area and Industry Position
Table 39. Thermo Fisher Scientific Inc. Company Profile and Main Business
Table 40. Thermo Fisher Scientific Inc. Tumor NGS Genetic Testing Models, Specifications, and Application
Table 41. Thermo Fisher Scientific Inc. Tumor NGS Genetic Testing Revenue and Gross Margin, US$ Million, 2018-2023
Table 42. Thermo Fisher Scientific Inc. Recent Developments
Table 43. DIAN DIAGNOSTICS Group Co., Ltd. Company Information, Head Office, Market Area and Industry Position
Table 44. DIAN DIAGNOSTICS Group Co., Ltd. Company Profile and Main Business
Table 45. DIAN DIAGNOSTICS Group Co., Ltd. Tumor NGS Genetic Testing Models, Specifications, and Application
Table 46. DIAN DIAGNOSTICS Group Co., Ltd. Tumor NGS Genetic Testing Revenue and Gross Margin, US$ Million, 2018-2023
Table 47. DIAN DIAGNOSTICS Group Co., Ltd. Recent Developments
Table 48. Burning Rock Biotech. Company Information, Head Office, Market Area and Industry Position
Table 49. Burning Rock Biotech. Company Profile and Main Business
Table 50. Burning Rock Biotech. Tumor NGS Genetic Testing Models, Specifications, and Application
Table 51. Burning Rock Biotech. Tumor NGS Genetic Testing Revenue and Gross Margin, US$ Million, 2018-2023
Table 52. Burning Rock Biotech. Recent Developments
Table 53. NovogeneCo.,Ltd. Company Information, Head Office, Market Area and Industry Position
Table 54. NovogeneCo.,Ltd. Company Profile and Main Business
Table 55. NovogeneCo.,Ltd. Tumor NGS Genetic Testing Models, Specifications, and Application
Table 56. NovogeneCo.,Ltd. Tumor NGS Genetic Testing Revenue and Gross Margin, US$ Million, 2018-2023
Table 57. NovogeneCo.,Ltd. Recent Developments
Table 58. Nanjing Shihejiyin Technology, Inc. Company Information, Head Office, Market Area and Industry Position
Table 59. Nanjing Shihejiyin Technology, Inc. Company Profile and Main Business
Table 60. Nanjing Shihejiyin Technology, Inc. Tumor NGS Genetic Testing Models, Specifications, and Application
Table 61. Nanjing Shihejiyin Technology, Inc. Tumor NGS Genetic Testing Revenue and Gross Margin, US$ Million, 2018-2023
Table 62. Nanjing Shihejiyin Technology, Inc. Recent Developments
Table 63. Amoy Diagnostics Co.,Ltd. Company Information, Head Office, Market Area and Industry Position
Table 64. Amoy Diagnostics Co.,Ltd. Company Profile and Main Business
Table 65. Amoy Diagnostics Co.,Ltd. Tumor NGS Genetic Testing Models, Specifications, and Application
Table 66. Amoy Diagnostics Co.,Ltd. Tumor NGS Genetic Testing Revenue and Gross Margin, US$ Million, 2018-2023
Table 67. Amoy Diagnostics Co.,Ltd. Recent Developments
Table 68. China National Pharmaceutical Group Corporation Company Information, Head Office, Market Area and Industry Position
Table 69. China National Pharmaceutical Group Corporation Company Profile and Main Business
Table 70. China National Pharmaceutical Group Corporation Tumor NGS Genetic Testing Models, Specifications, and Application
Table 71. China National Pharmaceutical Group Corporation Tumor NGS Genetic Testing Revenue and Gross Margin, US$ Million, 2018-2023
Table 72. China National Pharmaceutical Group Corporation Recent Developments
Table 73. Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Company Information, Head Office, Market Area and Industry Position
Table 74. Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Company Profile and Main Business
Table 75. Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Tumor NGS Genetic Testing Models, Specifications, and Application
Table 76. Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Tumor NGS Genetic Testing Revenue and Gross Margin, US$ Million, 2018-2023
Table 77. Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Recent Developments
Table 78. Guangzhou Kingmed Diagnostics Group Co.,Ltd. Company Information, Head Office, Market Area and Industry Position
Table 79. Guangzhou Kingmed Diagnostics Group Co.,Ltd. Company Profile and Main Business
Table 80. Guangzhou Kingmed Diagnostics Group Co.,Ltd. Tumor NGS Genetic Testing Models, Specifications, and Application
Table 81. Guangzhou Kingmed Diagnostics Group Co.,Ltd. Tumor NGS Genetic Testing Revenue and Gross Margin, US$ Million, 2018-2023
Table 82. Guangzhou Kingmed Diagnostics Group Co.,Ltd. Recent Developments
Table 83. ADICON Clinical Laboratories, Inc. Company Information, Head Office, Market Area and Industry Position
Table 84. ADICON Clinical Laboratories, Inc. Company Profile and Main Business
Table 85. ADICON Clinical Laboratories, Inc. Tumor NGS Genetic Testing Models, Specifications, and Application
Table 86. ADICON Clinical Laboratories, Inc. Tumor NGS Genetic Testing Revenue and Gross Margin, US$ Million, 2018-2023
Table 87. ADICON Clinical Laboratories, Inc. Recent Developments
Table 88. Genetron Company Information, Head Office, Market Area and Industry Position
Table 89. Genetron Company Profile and Main Business
Table 90. Genetron Tumor NGS Genetic Testing Models, Specifications, and Application
Table 91. Genetron Tumor NGS Genetic Testing Revenue and Gross Margin, US$ Million, 2018-2023
Table 92. Genetron Recent Developments
Table 93. Genecast Group Inc. Company Information, Head Office, Market Area and Industry Position
Table 94. Genecast Group Inc. Company Profile and Main Business
Table 95. Genecast Group Inc. Tumor NGS Genetic Testing Models, Specifications, and Application
Table 96. Genecast Group Inc. Tumor NGS Genetic Testing Revenue and Gross Margin, US$ Million, 2018-2023
Table 97. Genecast Group Inc. Recent Developments
Table 98. BGI Genomics Co.,Ltd. Company Information, Head Office, Market Area and Industry Position
Table 99. BGI Genomics Co.,Ltd. Company Profile and Main Business
Table 100. BGI Genomics Co.,Ltd. Tumor NGS Genetic Testing Models, Specifications, and Application
Table 101. BGI Genomics Co.,Ltd. Tumor NGS Genetic Testing Revenue and Gross Margin, US$ Million, 2018-2023
Table 102. BGI Genomics Co.,Ltd. Recent Developments
Table 103. Beijing-Geneplus Technology Limited. Company Information, Head Office, Market Area and Industry Position
Table 104. Beijing-Geneplus Technology Limited. Company Profile and Main Business
Table 105. Beijing-Geneplus Technology Limited. Tumor NGS Genetic Testing Models, Specifications, and Application
Table 106. Beijing-Geneplus Technology Limited. Tumor NGS Genetic Testing Revenue and Gross Margin, US$ Million, 2018-2023
Table 107. Beijing-Geneplus Technology Limited. Recent Developments
Table 108. Xiamen SpacegenCo., Ltd. Company Information, Head Office, Market Area and Industry Position
Table 109. Xiamen SpacegenCo., Ltd. Company Profile and Main Business
Table 110. Xiamen SpacegenCo., Ltd. Tumor NGS Genetic Testing Models, Specifications, and Application
Table 111. Xiamen SpacegenCo., Ltd. Tumor NGS Genetic Testing Revenue and Gross Margin, US$ Million, 2018-2023
Table 112. Xiamen SpacegenCo., Ltd. Recent Developments
Table 113. Geneis（Beijing）Co.Ltd. Company Information, Head Office, Market Area and Industry Position
Table 114. Geneis（Beijing）Co.Ltd. Company Profile and Main Business
Table 115. Geneis（Beijing）Co.Ltd. Tumor NGS Genetic Testing Models, Specifications, and Application
Table 116. Geneis（Beijing）Co.Ltd. Tumor NGS Genetic Testing Revenue and Gross Margin, US$ Million, 2018-2023
Table 117. Geneis（Beijing）Co.Ltd. Recent Developments
Table 118. HaploX Company Information, Head Office, Market Area and Industry Position
Table 119. HaploX Company Profile and Main Business
Table 120. HaploX Tumor NGS Genetic Testing Models, Specifications, and Application
Table 121. HaploX Tumor NGS Genetic Testing Revenue and Gross Margin, US$ Million, 2018-2023
Table 122. HaploX Recent Developments
List of Figures
Figure 1. Tumor NGS Genetic Testing Picture
Figure 2. Global Tumor NGS Genetic Testing Consumption Value, (US$ million) & (2018-2029)
Figure 3. China Tumor NGS Genetic Testing Consumption Value, (US$ million) & (2018-2029)
Figure 4. By Consumption Value, China Tumor NGS Genetic Testing Market Share of Global, 2018-2029
Figure 5. Global Tumor NGS Genetic Testing Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 6. China Tumor NGS Genetic Testing Key Participants, Market Share, 2022
Figure 7. Tumor NGS Genetic Testing Industry Chain
Figure 8. Tumor NGS Genetic Testing Procurement Model
Figure 9. Tumor NGS Genetic Testing Sales Model
Figure 10. Tumor NGS Genetic Testing Sales Channels, Direct Sales, and Distribution
Figure 11. Liquid Biopsy (Blood Sample)
Figure 12. Tissue Biopsy
Figure 13. By Type, Global Tumor NGS Genetic Testing Consumption Value, 2018-2029, US$ Million
Figure 14. By Type, Global Tumor NGS Genetic Testing Consumption Value Market Share, 2018-2029
Figure 15. Companion Diagnostics
Figure 16. Early Cancer Screening
Figure 17. Drug Discovery
Figure 18. By Application, Global Tumor NGS Genetic Testing Consumption Value, 2018-2029, US$ Million
Figure 19. By Application, Global Tumor NGS Genetic Testing Consumption Value Market Share, 2018-2029
Figure 20. By Region, Global Tumor NGS Genetic Testing Consumption Value Market Share, 2018-2029
Figure 21. North America Tumor NGS Genetic Testing Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 22. By Country, North America Tumor NGS Genetic Testing Consumption Value Market Share, 2022
Figure 23. Europe Tumor NGS Genetic Testing Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 24. By Country, Europe Tumor NGS Genetic Testing Consumption Value Market Share, 2022
Figure 25. Asia Pacific Tumor NGS Genetic Testing Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 26. By Country/Region, Asia Pacific Tumor NGS Genetic Testing Consumption Value Market Share, 2022
Figure 27. South America Tumor NGS Genetic Testing Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 28. By Country, South America Tumor NGS Genetic Testing Consumption Value Market Share, 2022
Figure 29. Middle East & Africa Tumor NGS Genetic Testing Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 30. U.S. Tumor NGS Genetic Testing Consumption Value, 2018-2029, US$ Million
Figure 31. By Type, U.S. Tumor NGS Genetic Testing Consumption Value Market Share, 2022 VS 2029
Figure 32. By Application, U.S. Tumor NGS Genetic Testing Consumption Value Market Share, 2022 VS 2029
Figure 33. Europe Tumor NGS Genetic Testing Consumption Value, 2018-2029, US$ Million
Figure 34. By Type, Europe Tumor NGS Genetic Testing Consumption Value Market Share, 2022 VS 2029
Figure 35. By Application, Europe Tumor NGS Genetic Testing Consumption Value Market Share, 2022 VS 2029
Figure 36. China Tumor NGS Genetic Testing Consumption Value, 2018-2029, US$ Million
Figure 37. By Type, China Tumor NGS Genetic Testing Consumption Value Market Share, 2022 VS 2029
Figure 38. By Application, China Tumor NGS Genetic Testing Consumption Value Market Share, 2022 VS 2029
Figure 39. Japan Tumor NGS Genetic Testing Consumption Value, 2018-2029, US$ Million
Figure 40. By Type, Japan Tumor NGS Genetic Testing Consumption Value Market Share, 2022 VS 2029
Figure 41. By Application, Japan Tumor NGS Genetic Testing Consumption Value Market Share, 2022 VS 2029
Figure 42. South Korea Tumor NGS Genetic Testing Consumption Value, 2018-2029, US$ Million
Figure 43. By Type, South Korea Tumor NGS Genetic Testing Consumption Value Market Share, 2022 VS 2029
Figure 44. By Application, South Korea Tumor NGS Genetic Testing Consumption Value Market Share, 2022 VS 2029
Figure 45. Southeast Asia Tumor NGS Genetic Testing Consumption Value, 2018-2029, US$ Million
Figure 46. By Type, Southeast Asia Tumor NGS Genetic Testing Consumption Value Market Share, 2022 VS 2029
Figure 47. By Application, Southeast Asia Tumor NGS Genetic Testing Consumption Value Market Share, 2022 VS 2029
Figure 48. India Tumor NGS Genetic Testing Consumption Value, 2018-2029, US$ Million
Figure 49. By Type, India Tumor NGS Genetic Testing Consumption Value Market Share, 2022 VS 2029
Figure 50. By Application, India Tumor NGS Genetic Testing Consumption Value Market Share, 2022 VS 2029
Figure 51. Middle East & Africa Tumor NGS Genetic Testing Consumption Value, 2018-2029, US$ Million
Figure 52. By Type, Middle East & Africa Tumor NGS Genetic Testing Consumption Value Market Share, 2022 VS 2029
Figure 53. By Application, Middle East & Africa Tumor NGS Genetic Testing Consumption Value Market Share, 2022 VS 2029
Figure 54. Research Methodology
Figure 55. Breakdown of Primary Interviews
Figure 56. Bottom-up and Top-down Approaches
Figure 57. Top-down Approaches

Reason to Buy

• Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
• Highlights key business priorities in order to assist companies to realign their business strategies
• The segment that is expected to dominate the Pharma & Healthcare Market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets